近期晶华新材(603683)发布2025年一季报，证券之星财报模型分析如下： 营收与利润 晶华新材(603683)在2025年一季度实现了4.38亿元的营业总收入，同比增长了12.67%。然而，归母净利 润却出现了下滑，从2024年同期的2157.97万元下降至1879.07万元，降幅为12.92%。扣非净利润也从 2105.05万元降至1858.2万元，同比减少了11.73%。 晶华新材的业绩主要依赖于研发、股权融资及资本开支驱动。公司自上市以来累计融资总额为7.32亿 元，累计分红总额为7094.29万元，分红融资比为0.1。需要注意的是，资本开支项目的合理性以及是否 存在资金压力是投资者应重点关注的问题。 总结 总体来看，晶华新材在2025年一季度虽然实现了营收的增长，但利润出现下滑，且应收账款、现金流和 债务状况均存在一定风险，需持续关注这些方面的变化。 债务状况 有息负债从2024年一季度的5.96亿元增加到2025年一季度的7.57亿元，同比增长了26.92%，有息资产负 债率达到了26.78%，需关注公司的债务偿还能力。 主要财务指标 商业模式与资本运作 毛利率：2025年一季度毛利率为16.8 ...

Core Viewpoint - CITIC Securities maintains its leading position in revenue and total assets despite mergers among domestic top brokerages [1] Financial Performance - In Q1 2025, CITIC Securities reported operating revenue of 17.76 billion yuan, ranking first in the industry, with a year-on-year growth of 29.13% [2] - The net profit for the same period was 6.55 billion yuan, reflecting a year-on-year increase of 32.00% [2] - Total assets reached 1.79 trillion yuan at the end of Q1, also ranking first in the industry [3] Revenue Growth Drivers - The revenue growth is attributed mainly to increases in wealth management and investment trading business [4] - Investment income saw a remarkable increase of 535.36% year-on-year, rising from 2.28 billion yuan in Q1 2024 to 14.50 billion yuan in Q1 2025 [5][6] Business Segment Performance - All core business segments, including brokerage, investment banking, and asset management, experienced positive year-on-year growth [7] - Specific figures include: - Brokerage net commission income of 3.33 billion yuan, up 36% year-on-year [8] - Investment banking net commission income of 976 million yuan, up 12% year-on-year [8] - Asset management net commission income of 2.56 billion yuan, up 8.69% year-on-year [8] Other Financial Metrics - Operating income from non-operating activities increased over 46 times, primarily due to increased default payments collected by subsidiaries [10] - Fair value changes were negatively impacted by market fluctuations, leading to a significant decrease in fair value gains [11] - Credit impairment losses increased significantly due to provisions for lent funds and repurchased financial assets [12] Subsidiary Performance - CITIC Securities' subsidiary, Huaxia Fund, reported a net profit of 561 million yuan in Q1 2025, continuing its profitable trend [16]

Investment Rating - The report assigns a "Buy" rating for Chengdu Bank, indicating a positive outlook for the stock over the next six months [15]. Core Insights - Chengdu Bank reported a total operating income of 22.98 billion yuan in 2024, reflecting a year-on-year growth of 5.89%. The net profit attributable to shareholders reached 12.86 billion yuan, up 10.17% year-on-year [2][3]. - The bank's net interest income grew by 4.57% to 18.46 billion yuan, accounting for 80.33% of total revenue, although this represents a slight decrease in proportion compared to the previous year [3][17]. - The loan portfolio expanded significantly, with total loans amounting to 741.32 billion yuan, a year-on-year increase of 18.72%. Corporate loans grew by 20.25% to 602.62 billion yuan, while personal loans increased by 12.46% to 138.70 billion yuan [3][4]. - Deposits also saw growth, reaching 865.71 billion yuan, up 13.20% year-on-year. Personal deposits grew by 23.79%, now making up 50.64% of total deposits [4]. - The bank's net interest margin was reported at 1.66%, a decrease of 0.15 percentage points year-on-year, but the decline in margin has narrowed compared to previous periods [4][18]. - Asset quality improved, with a non-performing loan ratio of 0.66%, down 0.02 percentage points year-on-year. Corporate loans showed a non-performing rate of 0.63%, while personal loans increased to 0.78% [5][20]. - Capital adequacy ratios improved, with the core Tier 1 capital ratio at 9.06%, up 0.84 percentage points year-on-year [5][22]. Financial Summary - The bank's total assets reached 1.25 trillion yuan, a year-on-year increase of 14.56% [16]. - Forecasted net profits for 2025, 2026, and 2027 are expected to be 14.13 billion yuan, 15.46 billion yuan, and 16.71 billion yuan, respectively, indicating continued growth [5][26].

| | | Three months ended | | | | --- | --- | --- | --- | --- | | in € m | Mar31. | Mar 31. | Absolute | Change | | (unless stated otherwise) | 2025 | 2024 | Change | in % | | Total net revenues, of which: | 8,524 | 7.779 | 745 | 10 | | Corporate Bank | 1,866 | 1,878 | (12) | (1) | | Investment Bank | 3,362 | 3,047 | 316 | 10. | | Private Bank | 2,439 | 2,376 | 62 | 3 | | Asset Management | 730 | 617 | 113 | 18 | | Corporate & Other | 127 | (139) | 266 | N/M | | Provision for credit losses | 471 | 439 | 32 | ...

Core Insights - The company reported a revenue of 8.98 billion yuan for 2024, representing a year-on-year growth of 9.7% [1] - Excluding infection protection products, the revenue was 8.62 billion yuan, with a year-on-year growth of 18.6% [1] - The net profit attributable to shareholders was 700 million yuan, showing a year-on-year increase of 19.8% [1] - The non-recurring net profit attributable to shareholders was 590 million yuan, reflecting a year-on-year growth of 43.4% [1] Business Segments - The company operates in two main business segments: medical consumables and consumer products [1] - The medical consumables segment, branded as Winner, generated a revenue of 3.91 billion yuan, with a slight year-on-year increase of 1.1% [1] - The consumer products segment, branded as Purcotton, achieved a revenue of 4.99 billion yuan, marking a year-on-year growth of 17.1% [1] Profit Distribution - The board approved a profit distribution plan, proposing a cash dividend of 2.5 yuan per 10 shares (including tax), with no bonus shares [1] - The total cash dividend for 2024 is 379 million yuan (including tax), accounting for 54.43% of the net profit attributable to shareholders [2] - The mid-year cash dividend was 4 yuan per 10 shares, totaling 233 million yuan [2] Recent Performance - In the first quarter of 2025, the company reported a revenue of 2.605 billion yuan, reflecting a year-on-year growth of 36.47% [2] - The net profit attributable to shareholders for the first quarter was 249 million yuan, with a year-on-year increase of 36.26% [2]

事件：常熟银行披露2025 年一季报，1Q25 实现营收30 亿元，同比增长10.0%，实现归母净利润11 亿 元，同比增长13.8%。1Q25 不良率季度环比下降1bp 至0.76%，拨备覆盖率季度环比下降11pct 至 490%。 集中兑现债市投资收益叠加利息净收入平稳正增支撑营收延续双位数增长，业绩增速略有放缓但预计仍 保持行业第一梯队。1Q25 营收同比增长10.0%（2024：10.5%），归母净利润同比增长 13.8%（2024:16.2%）。细拆驱动因子，① 一季度非息收入高增，一方面源自4Q24 滞后反映债市浮 盈，另一方面也体现1Q25 国债利率明显回升前及时兑现的精准择时。1Q25 非息收入同比增长62%，贡 献营收增速9.3pct，投资相关其他非息增长49%（4Q24 同比下降17%），贡献营收增速7.1pct。② 以量 补价下利息净收入延续正增长。 1Q25 利息净收入同比增长0.9%，规模扩张（正贡献7.4pct）对冲息差收窄扰动（拖累6.7pct）。③ 主动 处置、增提拨备夯实资产质量，拨备小幅拖累利润增速0.3pct。 一季报关注点：① 信贷投放主动降速，全年主线回归小微本源、优 ...

江苏银行核心营收高增，存贷两旺，息差提升，资产质量改善。 数据概览 2025Q1营收同比增长6.2%，增速较24A放缓2.6pc；归母净利润同比增长8.2%，增速较24A 放缓2.6pc。 2025Q1 末不良率0.86%，较年初下降3bp；2025Q1 末拨备覆盖率344%，较24A 末下降7pc。 核心营收高增 江苏银行25Q1 营收利润同比增速均达到5%+，业绩增速处在上市行靠前水平。 江苏银行较强的营收主要得益于核心营收改善，江苏银行25Q1 利息净收入和中收分别同比增长 21.9%、21.8%，分别较24A 提升16pc、18pc。 展望2025 年，江苏银行营收和利润增速有望维持中高个位数增长，主要考虑： ①Q1 贷款增长较强，为全年营收奠定了良好基础。②江苏银行25Q1 大幅加仓债券投资资产，25Q1 债 券投资同比增长30%，增速较24Q4 提升6pc。判断江苏银行在3 月市场利率短期高点积极把握机会，积 累了投资浮盈。 存贷实现高增 江苏银行25Q1 存贷两旺，25Q1 贷款和存款净增量分别占2024 年全年贷款和存款净增量的83%、 125%，体现了江苏银行较强的资产组织能力，同时贷款靠前 ...

营收与利润 欧克科技在2025年一季度实现了显著的营收增长，营业总收入达到1.99亿元，同比增长58.9%。归母净 利润为4053.36万元，同比增长25.61%。值得注意的是，扣非净利润达到了3595.96万元，同比增长 83.7%，显示出公司在主营业务上的强劲表现。 盈利能力 尽管营收和利润增长显著，但公司的盈利能力指标有所分化。毛利率为36.75%，同比增加了1.63个百分 点；然而，净利率为20.95%，同比下降了18.6%。这表明公司在成本控制方面可能面临一定压力。 费用控制 公司在费用控制方面表现出色，销售费用、管理费用、财务费用总计为1669.12万元，三费占营收比为 8.38%，同比下降了18.19%。这反映了公司在运营效率上的提升。 近期欧克科技（001223）发布2025年一季报，证券之星财报模型分析如下： 现金流与资产负债 公司货币资金为5.53亿元，较去年同期下降26.81%。每股经营性现金流为0.64元，同比下降32.02%。此 外，应收账款为4.37亿元，同比增加60.42%，应收账款的快速增长值得关注。有息负债为1.38亿元。 商业模式与资本结构 公司业绩主要依靠研发及股权融资驱 ...

近期福然德（605050）发布2024年年报，证券之星财报模型分析如下： 经营概况 福然德在2024年的营业总收入达到了112.78亿元，同比上升15.54%。然而，归母净利润为3.17亿元，同 比下降24.11%，扣非净利润为2.78亿元，同比下降28.89%。这表明尽管公司在营业收入方面有所增长， 但在盈利能力上遇到了挑战。 利润分析 毛利率与净利率 公司的毛利率为5.13%，同比减少了26.14%，净利率为2.9%，同比减少了33.45%。毛利率和净利率的显 著下降反映了公司在成本控制和产品定价方面面临的压力。 季度表现 截至报告期末，公司应收账款为21.02亿元，同比增加了40.66%。应收账款的大幅增加可能意味着公司 在回款方面遇到了困难，需要密切关注其对现金流的影响。 现金流 每股经营性现金流为0.14元，同比增加了112.88%。虽然这一指标有所改善，但公司近3年经营性现金流 均值/流动负债仅为-2.96%，表明公司整体现金流状况仍需谨慎对待。 负债情况 有息负债为12.57亿元，同比增加了202.83%。较高的有息负债水平可能会对公司未来的偿债能力带来一 定压力。 成本与费用 三费 销售费用、 ...

营收与利润 华康股份在2025年一季度实现了营业总收入8.17亿元，较去年同期的6.35亿元同比增长了28.63%。然 而，归母净利润为8103.75万元，仅同比增长1.30%，扣非净利润为7325.76万元，同比增长0.19%。这表 明公司在营业收入大幅增长的同时，净利润的增长相对较为缓慢。 毛利率与净利率 公司的毛利率为19.4%，同比下降了19.21%，净利率为9.99%，同比下降了20.7%。这反映出公司在成本 控制方面可能面临一定压力，导致盈利能力有所下降。 近期华康股份（605077）发布2025年一季报，证券之星财报模型分析如下： 总结 应收账款与现金流 值得注意的是，公司的应收账款从去年同期的3.76亿元增加到5.37亿元，同比增长了42.66%。同时，每 股经营性现金流为-0.12元，虽然较去年同期的-0.65元有所改善，但仍为负值。这提示公司需关注应收 账款的回收情况以及现金流的健康状况。 资产负债状况 公司的有息负债为28.06亿元，同比增长了20.36%，有息资产负债率已达36.9%。此外，货币资金为8.09 亿元，较去年同期的17.16亿元减少了52.83%，货币资金与流动负债的比例 ...